SCHEMBL17472292

SCHEMBL17472292

CCC(I)c1cc(OC)c(OC)c(OC)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.47
ACHE P22303 1/20 0.46
MAPT P10636 4/20 0.45
CYP3A4 P08684 1/20 0.45
CA9 Q16790 1/20 0.45
MAPK1 P28482 2/20 0.44
TUBB1 Q9H4B7 4/20 0.42
TUBB4A P04350 3/20 0.42
TUBB P07437 3/20 0.42
TUBA3C P0DPH7 3/20 0.42
TUBA1B P68363 3/20 0.42
TUBA4A P68366 3/20 0.42
TUBB4B P68371 3/20 0.42
TUBB3 Q13509 3/20 0.42
TUBB2A Q13885 3/20 0.42
TUBB8 Q3ZCM7 3/20 0.42
TUBA3E Q6PEY2 3/20 0.42
TUBA1A Q71U36 3/20 0.42
TUBA1C Q9BQE3 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110894 0.77 PTGS2 (0.54) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL2618698 0.77 PTGS2 (0.54) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL4098658 0.77 PTGS2 (0.54) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL12659351 0.75 PTGS2 (0.52) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL7752210 0.75 PTGS2 (0.52) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL2007010 0.75 TUBB4A (0.58) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL24779578 0.73 PTGS2 (0.50) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL9136813 0.73 PTGS2 (0.50) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL23682245 0.73 PTGS2 (0.50) PTGS2L3MBTL1ACHEMAPTCYP3A4
SCHEMBL18925030 0.73 PTGS2 (0.50) PTGS2L3MBTL1ACHEMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160022642-A1 Compounds Useful for Promoting Protein Degradation and Methods Using Same YALE UNIVERSITY 2016-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160022642-A1 Compounds Useful for Promoting Protein Degradation and Methods Using Same AR, SHBG, PSMG3 PTGS2 3176/4885L3MBTL1 1936/4885ACHE 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.